A Phase 3B Multi-Center Open-Label Study to Evaluate the Safety of Abatacept in Subjects Who Switch From Intravenous to Subcutaneous Abatacept Therapy.
Phase of Trial: Phase III
Latest Information Update: 17 Mar 2015
At a glance
- Drugs Abatacept (Primary) ; Pneumococcal vaccine
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms ATTUNE
- Sponsors Bristol-Myers Squibb
- 10 Jun 2017 Biomarkers information updated
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 23 Mar 2012 Actual patient number is 123 according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History